NHS rollout of artificial pancreas narrows inequality in diabetes care
The NHS has rolled out an artificial pancreas for type 1 diabetes patients, significantly improving access for deprived and minority ethnic groups. This device combines a continuous glucose monitor and an insulin pump, easing the management of blood sugar levels. Early results show a minimal disparity in uptake between different socioeconomic and ethnic backgrounds, marking a positive shift in diabetes care equity.
- ▪The artificial pancreas rollout has narrowed ethnic and socioeconomic inequality in diabetes treatment access.
- ▪More than 150,000 adults and children with type 1 diabetes are expected to receive the device from the NHS.
- ▪The first two years of the rollout have seen 72.3% of eligible children fitted with the device.
Opening excerpt (first ~120 words) tap to expand
The device, which includes a continuous glucose monitor and an insulin pump, removes much of the mental burden of managing blood sugar levels. Photograph: ICRMView image in fullscreenThe device, which includes a continuous glucose monitor and an insulin pump, removes much of the mental burden of managing blood sugar levels. Photograph: ICRMDiabetesNHS rollout of artificial pancreas narrows inequality in diabetes careExclusive: People from deprived and minority ethnic backgrounds have better access to device than for previous technologiesTobi Thomas Health and inequalities correspondent Tue 19 May 2026 03.00 EDTSharePrefer the Guardian on GoogleThe rollout of a “life-changing” artificial pancreas on the NHS for people with type 1 diabetes has helped to narrow ethnic and socioeconomic…
Excerpt limited to ~120 words for fair-use compliance. The full article is at the Guardian.
Discussion
0 commentsMore from the Guardian
